Skip to main content
SLGNSilgan Holdings Inc.Sell5.6·$45.08+0.91%
SLGN · Why this verdict

Why Silgan Holdings (SLGN) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Silgan Holdings trades at a forward price-to-earnings ratio of 10 times with a price-to-earnings growth ratio of 0.19 and analysts see 31% upside, but a confirmed price downtrend, mixed earnings history, and an officer departure signal create near-term uncertainty despite the attractive valuation.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Silgan trades at a forward price-to-earnings ratio of 10 times and a price-to-earnings growth ratio of 0.19, which is below 1.0 and indicates the market is pricing in little or no future earnings growth despite the company's historical track record in packaging.

Stable
Valuation breakdown
Expectation
The forward price-to-earnings ratio expands toward 13 times as investors recognize the disconnect between valuation and earnings power, driving the stock to at least $46 within 12 months.

CounterPackaging companies facing leverage penalties and a confirmed downtrend often deserve lower multiples; the 2.0 debt-to-equity ratio adds risk and may explain why the market is discounting the stock.

An officer departure or appointment was flagged in recent regulatory filings, introducing management execution uncertainty at a time when the company is navigating a price downtrend and leverage reduction objectives.

Stable
Gates warning
Expectation
New leadership is publicly confirmed and no further executive departures are announced in the next 6 months, providing continuity to the recovery thesis.

CounterRoutine executive transitions in well-established companies often have limited operational impact; Silgan's institutional packaging operations are largely process-driven and less dependent on any single executive.

Silgan beat estimates in 2 of the last 4 quarters and missed in 2 quarters, with recent beats of 4.9% and 4.4% in the most recent two quarters suggesting a potential improvement trend after the prior misses.

Stable
Earnings
Expectation
Earnings beat rate improves to at least 3 of 4 quarters over the next year with average surprise exceeding 3%.

CounterThe prior 2 misses included a -3.8% shortfall, and earnings guidance is unknown; a return to misses would confirm the company is not executing a clean recovery.

The stock is below its 200-day moving average with the average declining at 3.5% per month, indicating a confirmed downtrend, though MACD is improving and RSI has reached 71 suggesting a possible near-term recovery bounce from oversold conditions.

Stable
Momentum breakdown
Expectation
Stock price crosses above its 200-day moving average within 6 months and sustains above it for at least 30 consecutive days.

CounterAn RSI of 71 while below the 200-day moving average is a characteristic bear rally signal; in the absence of a catalyst the overbought reading could lead to another leg down.

Per-dimension breakdown

Value

8.0/10data confidence 100%
ComponentSub-score
P/E7.5
P/S9.8
EV/EBITDA6.4
Fwd P/E9.2
PEG10.0
Analyst target5.0
  • Forward P/E: 10.9x
  • PEG: 0.21
  • Attractively valued

Quality

4.0/10data confidence 100%
ComponentSub-score
ROE4.3
ROA3.0
Gross margin0.0
Op margin3.5
Net margin2.2
Current ratio4.8
FCF quality6.9
Moat4.8
Piotroski F6.7
  • No competitive moat

Growth

7.0/10data confidence 67%
ComponentSub-score
Rev growth4.1
EPS growth10.0

Momentum

6.2/10data confidence 100%
ComponentSub-score
RSI3.3
MACD10.0
OBV10.0
MA position7.5
Volume0.0
  • Overbought (RSI 94)
  • Volume accumulation (rising OBV)
  • Above 200-MA but MA slope flat/negative + RSI 94 (late-cycle distribution risk)

Sentiment

5.8/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target7.5
erm sentiment5.0

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

5.0/10data confidence 80%
ComponentSub-score
value rank6.9
quality rank4.3
growth rank3.8

Technical

2.2/10data confidence 100%
ComponentSub-score
bollinger0.2
support resistance0.2
52w position6.1

Risk (lower is worse)

3.9/10data confidence 100%
ComponentSub-score
short interest5.2
days to cover0.0
volatility5.3
put call0.0
implied vol5.6
max pain risk3.0
beta8.8
debt equity3.0
  • Elevated put/call: 11.00
  • Above max pain $30
  • Concentration risks: 2 MED (10-K Item 1A)

Catalyst

5.2/10data confidence 100%
ComponentSub-score
erm5.0
earnings history5.6
earnings timing5.0
surprise avg3.4
dividend safety7.0
  • Dividend: 188.0%

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • MOMENTUM:6.2>=5.5
  • INSIDER:OK
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:34d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:0.2<1.5@spot
Warning (2)
  • DEATH_CROSS:momentum=6.2>=5.0 recovering
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
0.17
Upside
+2.6%
Downside
15.0%
Sizing output
AVOID

SetupRECOVERY Death cross but MACD improving, RSI 94

EdgeNO_EDGE No clear edge identified

SuitabilityAGGRESSIVE MCap $4.7B<$5B

Investment implication

The F-path SELL output reflects an overall score of 4.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 8.0) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:0.2<1.5@spot) reinforce the read. Current asymmetry R:R is 0.17 — supplementary context, not the trigger for this path.

The strongest dimensions are Value at 8.0, Growth at 7.0, and Momentum at 6.2; the weakest are Technical at 2.2, Risk (lower is worse) at 3.9, and Quality at 4.0. The V9 engine flagged 1 failed gate with 2 warnings, producing an asymmetric reward-to-risk of 0.17 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Silgan trades at a forward price-to-earnings ratio of 10 times and a price-to-earnings growth ratio of 0.19, which is below 1.0 and indicates the market is pricing in little or no future earnings growth despite the company's historical track record in packaging.

    Trip ifForward price-to-earnings ratio expands above 16 times without a corresponding earnings increase, indicating the valuation gap has closed and the thesis is complete.

  • P2Silgan beat estimates in 2 of the last 4 quarters and missed in 2 quarters, with recent beats of 4.9% and 4.4% in the most recent two quarters suggesting a potential improvement trend after the prior misses.

    Trip ifEPS surprise falls below negative 5% in at least 2 of the next 3 quarters.

  • P3The stock is below its 200-day moving average with the average declining at 3.5% per month, indicating a confirmed downtrend, though MACD is improving and RSI has reached 71 suggesting a possible near-term recovery bounce from oversold conditions.

    Trip ifStock price drops below $35, more than 14% below the current price of $40.74.

  • P4An officer departure or appointment was flagged in recent regulatory filings, introducing management execution uncertainty at a time when the company is navigating a price downtrend and leverage reduction objectives.

    Trip ifMore than 2 additional executive departures are announced within 6 months.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks SLGN Why this verdict